-
Presence & voting results
Here you will find the presence and voting results at the AGM 2026.
Read more -
Speech by the CEO
Speech by Belén Garijo, Chair of the Executive Board and CEO.
Read the Speech
Select your Market
-
- Algeria
- Angola
- Benin
- Botswana
- Burkina Faso
- Burundi
- Cameroon
- Cape Verde
- Central African Republic
- Chad
- Comoros
- Congo
- Congo Democratic Republic
- Djibouti
- Egypt
- Equatorial Guinea
- Eritrea
- Ethiopia
- Gabon
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Ivory Coast
- Kenya
- Lesotho
- Liberia
- Libya
- Madagascar
- Malawi
- Mauritania
- Mauritius
- Morocco
- Mozambique
- Namibia
- Niger
- Nigeria
- Reunion Islands
- Rwanda
- Saint Helena
- São Tomé and Príncipe
- Senegal
- Seychelles
- Sierra Leone
- Somalia
- South Africa
- Sudan
- Swaziland
- Tanzania
- Togo
- Tunisia
- Uganda
- Zambia
- Zimbabwe
-
- Albania
- Austria
- Baltic Region
- Belarus
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Netherlands
- North Macedonia
- Norway
- Poland
- Portugal
- Romania
- Russian Federation
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Türkiye
- Ukraine
- United Kingdom
Annual General Meeting 2026
Annual General Meeting 2026
Merck KGaA, Darmstadt, Germany held its 31st Annual General Meeting as in-person event on April 24, 2026 in Frankfurt-Höchst (Germany). All of the resolutions on the agenda were approved, including the dividend of € 2.20 per share.
Documents and further information for the AGM 2026
| Download | ||
|---|---|---|
| Convening Notice of the Annual General Meeting of Merck KGaA, Darmstadt, Germany, on April 24 2026 | ||
| Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany (preliminary preview version as of April 16, 2026) | ||
| Presence and Voting Results | ||
| Dividend announcement | ||
| Information in accordance with Table 8 of the Regulation (EU) 2018/1212 (Dividend) | ||
| Explanation of Shareholder Rights | ||
| Information on Data Privacy for Shareholders | ||
| Form for proxies and exercising voting rights | ||
| Organizational information AGM | ||
| Technical Directions for the Investor Portal | PDF | |
| Document in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with Implementing Regulation (EU) 2018/1212 (GOR) | ||
| Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2025 including the consolidated financial statements, combined Management report and Supervisory Board report | ||
| Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2025 including the combined Management report | ||
| Compensation Report 2025 |